Next 10 |
2024-04-25 09:02:03 ET Avenue Therapeutics Inc (ATXI) announced stock split at a ratio of 1-for-75 on 2024-04-26 ... Full story available on KlickAnalytics.com
A look at the top 10 most actives in the United States Chicken Soup for the Soul Entertainment Inc. (CSSE) rose 179.3% to $0.4253 on volume of 213,352,319 shares Tesla Inc. (TSLA) rose 12.1% to $162.13 on volume of 179,967,315 shares PROSHARES TRUST (SQQQ) fell 0.8% to $11.81 on volume of...
A look at the top 10 most actives in the United States Chicken Soup for the Soul Entertainment Inc. (CSSE) rose 43.1% to $0.218 on volume of 39,190,339 shares Amesite Inc. (AMST) rose 100.0% to $4.0001 on volume of 36,290,765 shares Tesla Inc. (TSLA) rose 10.7% to $160.21 on volume of 32,...
2024-04-24 07:58:30 ET More on Avenue Therapeutics Avenue Therapeutics granted extension for Nasdaq compliance Seeking Alpha’s Quant Rating on Avenue Therapeutics Historical earnings data for Avenue Therapeutics Financial information for Avenue Therape...
MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced th...
MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced th...
2024-03-19 06:53:18 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Avenue Therapeutics (NASDAQ: ATXI ) just reported results for the fourth quarter of 2023. Avenue Therapeutics reported earnings per share of 56 cents. This was above the a...
2024-03-18 16:46:33 ET More on Avenue Therapeutics Avenue Therapeutics granted extension for Nasdaq compliance Avenue Therapeutics signs warrant exercise transactions for $5.0M in proceeds Seeking Alpha’s Quant Rating on Avenue Therapeutics Historical ...
- Enrollment completed in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data expected in second quarter of 2024 - - Presented positive BAER-101 preclinical data at American Epilepsy Society (AES) and American Society for Experimental Neurotherapeuti...
2024-03-15 08:53:49 ET More on Avenue Therapeutics Avenue Therapeutics signs warrant exercise transactions for $5.0M in proceeds Seeking Alpha’s Quant Rating on Avenue Therapeutics Historical earnings data for Avenue Therapeutics Financial information ...
News, Short Squeeze, Breakout and More Instantly...
Avenue Therapeutics Inc. Company Name:
ATXI Stock Symbol:
NASDAQ Market:
Avenue Therapeutics Inc. Website:
2024-04-25 09:02:03 ET Avenue Therapeutics Inc (ATXI) announced stock split at a ratio of 1-for-75 on 2024-04-26 ... Full story available on KlickAnalytics.com
U.S. stocks traded slightly lower toward the end of trading, with the S&P 500 edging lower on Wednesday. The Dow traded down 0.18% to 38,434.99...
A look at the top 10 most actives in the United States Chicken Soup for the Soul Entertainment Inc. (CSSE) rose 179.3% to $0.4253 on volume of 213,352,319 shares Tesla Inc. (TSLA) rose 12.1% to $162.13 on volume of 179,967,315 shares PROSHARES TRUST (SQQQ) fell 0.8% to $11.81 on volume of...